5-aryl thiazolidine-2,4-diones:: Discovery of PPAR dual α/γ agonists as antidiabetic agents

被引:62
|
作者
Desai, RC
Han, W
Metzger, EJ
Bergman, JP
Gratale, DF
MacNaul, KL
Berger, JP
Doebber, TW
Leung, K
Moller, DE
Heck, JV
Sahoo, SP
机构
[1] Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
[2] Merck Res Labs, Dept Metab Disorder, Rahway, NJ 07065 USA
[3] Merck Res Labs, Dept Drug Metab, Rahway, NJ 07065 USA
关键词
D O I
10.1016/S0960-894X(03)00505-5
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A novel series of 5-aryl tliiazolidine-2,4-diones based dual PPARalpha/gamma agonists was identified. A number of highly potent and orally bioavailable analogues were synthesized. Efficacy study results of some of these analogues in the db/db mice model of type 2 diabetes showed them superior to rosiglitazone in correcting hyperglycemia and hypertriglyceridemia. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2795 / 2798
页数:4
相关论文
共 50 条
  • [41] Synthesis and antimicrobial activity of 5-((3-aryl-1-phenyl-1H-pyrazol-4-yl)methylene)thiazolidine-2,4-diones
    Om Prakash
    Deepak K. Aneja
    Poonam Lohan
    Khalid Hussain
    Sanjiv Arora
    Chetan Sharma
    Kamal R. Aneja
    Medicinal Chemistry Research, 2012, 21 : 2961 - 2968
  • [42] Discovery of 3-(2-aminoethyl)-thiazolidine-2,4-diones as a novel chemotype of sigma-1 receptor ligands
    Elkholy, Nada
    Abdelwaly, Ahmad
    Mohamed, Karim
    Amata, Emanuele
    Lombino, Jessica
    Cosentino, Giuseppe
    Intagliata, Sebastiano
    Helal, Mohamed A.
    CHEMICAL BIOLOGY & DRUG DESIGN, 2022, 100 (01) : 25 - 40
  • [43] Design, Molecular Docking, Synthesis, Anticancer and Anti-Hyperglycemic Assessments of Thiazolidine-2,4-diones Bearing Sulfonylthiourea Moieties as Potent VEGFR-2 Inhibitors and PPARγ Agonists
    Abdelgawad, Mohamed A.
    El-Adl, Khaled
    El-Hddad, Sanadelaslam S. A.
    Elhady, Mostafa M.
    Saleh, Nashwa M.
    Khalifa, Mohamed M.
    Khedr, Fathalla
    Alswah, Mohamed
    Nayl, AbdElAziz A.
    Ghoneim, Mohammed M.
    Abd El-Sattar, Nour E. A.
    PHARMACEUTICALS, 2022, 15 (02)
  • [44] Synthesis and antidiabetic activity of some new 5-[1(4-chloro-2-phenethylsulfanyl-thiazol-5-yl)methyli-dene]-thiazolidine-2,4-diones
    Bozdag-Dundar, Ova
    Mentese, Arzu
    DRUGS OF THE FUTURE, 2007, 32 : 55 - 56
  • [45] QSAR and molecular modeling studies in imidazopyridinethiazolidine-2,4-diones:: PPARγ agonists
    Kapoor, A
    Kashaw, SK
    Saxena, AK
    MEDICINAL CHEMISTRY RESEARCH, 2004, 13 (8-9) : 770 - 780
  • [46] Exploration of thiazolidine-2,4-diones as tyrosine kinase inhibitors: Design, synthesis, ADMET, docking, and antiproliferative evaluations
    Aziz, Nada A. A. M.
    George, Riham F. F.
    El-Adl, Khaled
    Mahmoud, Walaa R. R.
    ARCHIV DER PHARMAZIE, 2023, 356 (03)
  • [47] QSAR AND MOLECULAR MODELING STUDIES IN IMIDAZOPYRIDINETHIAZOLIDINE-2,4-DIONES: PPARγ AGONISTS
    Amit Kapoor
    Sushil K. Kashaw
    Anil K. Saxena
    Medicinal Chemistry Research, 2004, 13 : 770 - 780
  • [48] Synthesis of a novel series of (Z)-3,5-disubstituted thiazolidine-2,4-diones as promising anti-breast cancer agents
    El-Kashef, Hussein
    Badr, Gamal
    El-Maali, Nagwa Abo
    Sayed, Douaa
    Melnyk, Patricia
    Lebegue, Nicolas
    Abd El-Khalek, Rofida
    BIOORGANIC CHEMISTRY, 2020, 96
  • [49] Pyridine-3-propanoic acids:: Discovery of dual PPARα/γ agonists as antidiabetic agents
    Humphries, Paul S.
    Bailey, Simon
    Almaden, Jonathon V.
    Barnum, Sandra J.
    Carlson, Thomas J.
    Christie, Lance C.
    Do, Quyen-Quyen T.
    Fraser, James D.
    Hess, Mary
    Kellum, Jack
    Kim, Young H.
    McClellan, Guy A.
    Ogilvie, Kathleen M.
    Simmons, Brett H.
    Skalitzky, Donald
    Sun, Shaoxian
    Wilhite, David
    Zehnder, Luke R.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (23) : 6120 - 6123
  • [50] Integrated fragment-based drug design and virtual screening techniques for exploring the antidiabetic potential of thiazolidine-2,4-diones: Design, synthesis and in vivo studies
    Gupta, Shankar
    Baweja, Gurkaran Singh
    Singh, Shamsher
    Irani, Mehdi
    Singh, Rajveer
    Asati, Vivek
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 261